Device Makers Have Funneled Billions to Orthopedic Surgeons Who Use Their Products
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
Multimedia
841 - 860 of 1,421 Results
-
-
In Alleged Health Care ‘Money Grab,’ Nation’s Largest Hospital Chain Cashes In on Trauma Centers
HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.
By Jay Hancock -
‘An Arm and a Leg’: When Your Insurance Company Says No, How to Ask for a Yes
Health care insiders get surprise medical bills, too. One of them shares tips for writing an insurance appeal.
-
KHN’s ‘What the Health?’: Our 200th Episode!
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
-
Montana Med School Clash Revives For-Profit Vs. Nonprofit Flap
Two medical schools vie to open in Montana, highlighting the rapid spread of for-profit schools and their previously tarnished business model.
-
In Missouri and Other States, Flawed Data Makes It Hard to Track Vaccine Equity
Racial and ethnic categories for vaccination data vary widely from one state to another, complicating efforts to distribute shots where they are needed most. In Missouri, some red flags in the data surfaced, making health officials question its usefulness.
-
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
-
Behind The Byline: Finding a ‘Superstar’ to Interview
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
By Jenny Gold -
In California, Nursing Home Owners Can Operate After They’re Denied a License
Nursing home chain ReNew Health continues to care for hundreds of patients even after the state attempted to crack down. Before and during the pandemic, homes connected to ReNew had safety violations.
-
Data Visualizations
Caring for an Aging Nation
The number of Americans 65 and older is expected to nearly double in the next 40 years. Finding a way to provide and pay for the long-term health services they need won't be easy.
-
KHN’s ‘What the Health?’: The Return of the Public Option
Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Enough to Wreck Their Rest: $10,322 for a Sleep Study
The University of Miami Health System charges a truck driver six times what Medicare would pay for an overnight test.
-
KHN’s ‘What the Health?’: Roe v. Wade on the Ropes
The newly conservative Supreme Court will hear a case that could overturn the nationwide right to abortion and cause political upheaval. Meanwhile, the Centers for Disease Control and Prevention’s abrupt announcement that vaccinated people can take off their masks in most places has caused upheaval of its own. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Stark Racial Disparities Persist in Vaccinations, State-Level CDC Data Shows
Black Americans’ vaccination rates still trail all other groups, while Hispanics show improvement. Native Americans show the strongest rates nationally.
-
Watch: Elisabeth Rosenthal on the Covid-19 ‘Infodemic’ and the Media
The journalists talked about how the nation's political divides made some people realize they could spread misinformation for political or financial gain.
-
Picture of Health
Homicides Surge in California Amid Covid Shutdowns of Schools, Youth Programs
California endured a brutal spike in homicides in 2020 across large swaths of the state, registering the largest year-over-year increase in victims in three decades. Experts cite as one significant factor a rise in gang violence fueled by pandemic shutdowns of schools, sports leagues and programs for at-risk youth.
-
Listen: Exploring Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights
KHN's Julie Rovner joins The Atlantic's “Social Distance” podcast, hosted by Dr. James Hamblin and Maeve Higgins, to talk about President Joe Biden's support for an initiative to waive patent protection for covid vaccines and the politics of drug policy in the United States.
-
KHN’s ‘What the Health?’: Drug Price Effort Hits a Snag
Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
-
Behind the Byline: The Quest to Bring Spanish Language to KHN
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
By Paula Andalo -
‘I Just Feel Like Myself’: A Nonbinary Child in Their Own Words
When they were 6, Hallel told their parents they are a boy-girl. At 9, they are helping their parents, grandparents and friends understand what it means to be nonbinary.